MedPath
PPB Approval

SUNLENCA SOLUTION FOR INJECTION 463.5MG/1.5ML

HK-68151

Prescription only Medicines

February 26, 2024

Company Information

Company Details

FLAT/RM 2603, 26/F, HYSAN PLACE, 500 HENNESSY ROAD, CAUSEWAY BAY, HONG KONG

Active Ingredients

lenacapavir (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUNLENCA SOLUTION FOR INJECTION 463.5MG/1.5ML - PPB 批准文号 | MedPath